Severe combined immunodeficiency diagnosis and genetic defects

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a life-threatening genetic disorder impacting immune cell development.
• It leaves infants highly susceptible to severe, recurrent infections.
• Over 20 genes are implicated, leading to various SCID forms.

Purpose of the Study:

• To summarize the nature of SCID, its symptoms, and diagnostic/treatment approaches.
• To highlight the importance of early detection and intervention.

Main Methods:

• Review of SCID's genetic basis and clinical presentation.
• Discussion of immune reconstitution therapies, including hematopoietic stem cell transplantation (HSCT) and gene therapy.
• Emphasis on the role of newborn screening.

Main Results:

• SCID presents at birth with symptoms like chronic diarrhea, thrush, and persistent infections.
• Without timely intervention, SCID carries a high mortality risk.
• Successful treatment allows patients to lead normal lives with ongoing monitoring.

Conclusions:

• SCID is a severe but treatable genetic immune deficiency.
• Early diagnosis through newborn screening is crucial for improving prognosis.
• HSCT and gene therapy offer effective treatment options for SCID.